T. Rowe Price Investment Management, Inc.
Position in MRK — Merck & Co., Inc.
CIK 1897612
BALTIMORE, MD
Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,071,176
+$76,378 QoQ
Shares Held
8,336
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,067
of 3,781 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $130,347,685 across 8 Drug Manufacturers - General names. MRK ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,482 | $60,549,630 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
276,379 | $34,917,722 | |
| 3 | BIIB |
Biogen Inc.
|
113,873 | $24,603,400 | |
| 4 | JNJ |
Johnson & Johnson
|
19,637 | $4,987,208 | |
| 5 | ABBV |
AbbVie Inc.
|
5,805 | $1,460,770 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,400 | $1,405,928 | |
| 7 | PFE |
Pfizer Inc
|
56,140 | $1,351,851 | |
| 8 | MRK |
Merck & Co., Inc.
This page
|
8,336 | $1,071,176 |
All Filings in MRK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,071,176 | 8,336 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $994,798 | 8,270 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||